New designer lipid-like peptide with lipid nanostructures for drug delivery systemsMay 30, 2007Scientists from Institute of Biophysics and Nanosystems Research (IBN), Austrian Academy of Sciences and of Centre for Biomedical Engineering, Massachusetts Institute of Technology, Cambridge, USA report the study of "Tuning Curvature and Stability of Monoolein Bilayers by Designer Lipid-Like Peptide Surfactants" in the May 30th issue of the online, open-access journal PLoS ONE. Their findings not only help us to understand the basic science of how lipid-like peptides interact with lipid molecules, but also may provide new strategies for the encapsulation and the delivery of biological active materials. They detailed their findings in the report on the impact of integrating short surfactant-like designer peptides in lipidic nanostructures. Anan Yaghmur, Michael Rappolt, Peter Laggner and Shuguang Zhang reported the formations of dynamic nanostructures of lipid-like peptides that are like two-headed Janus, both water-loving and water-hating, which represent a new class of designer materials using common amino acids, the same basic molecules from meat, beans and fruits. These lipid-like peptides have excellent potential to solubilize membrane proteins and enzymes, and - as now demonstrated - can also be utilized to stabilize different self-assembled liquid crystalline nanostructures. Moreover, the surface charge density of lipidic nanostructures can be varied in a simple manner. Dr. Anan Yaghmur, first author of the study, comments on the study, "the addition of small amounts of designer lipid-like peptides is sufficient to form systems with excellent potential for various biotechnological applications such as the encapsulation of water-insoluble drugs and the delivery of biological active materials."
Currently, many anticancer drugs are difficult to deliver to patients due to their difficulty to be soluble in water. "This is a systematic study to combine with lipid molecules," Shuguang Zhang of MIT, a co-author said, "people have been curious about if these similar molecules can interact. This study provided the first answer". "Since these lipid-like peptides can be designed, just like to design an elegant watch, an art object, a music instrument, a ski, or a pair of sunglasses, we have the ultimate control to the outcome of the structure and their properties" Zhang added. This study stemmed from a scientific visit by Peter Laggner to Shuguang Zhang at MIT in Cambridge, USA in May 2006. They shared some ideas and decided to collaborate since Laggner is a world-expert on nanostructure using small angle X-ray scattering and Zhang can provide the designer lipid-like peptides that he has been studied since 2000. In the near future, many colloidal aqueous dispersions, which are similar to milk and some paints, with confined inner nanostructures, will offer unique characteristics like high drug load capacities and low viscosity. Here these designer lipid-like peptides may play a key role in improving effective drug delivery systems. Public Library of Science Science News and Science Current Events Tag Cloud This tag cloud is a visual representation of term frequencies of random science news topics with common terms grouped together and emphasized by their display size. Pollution Leukemia Ovarian Tissue Penguins Preterm Birth Antidepressant Sexual Selection Vitamin D Medulloblastoma Child Abuse Heterochromatin Digital Camera Emotions Anxiety Disorders Cavities life on Mars Negative Emotion Glacier Chest Pain Power Grid Bison Glycemic Index Hubble Space Telescope Arctic Ice Prescription Drugs
See More: Science News Tags | |||||||||||||||||||||
|
Related Peptides Current Events and Peptides News Articles Alzheimer's research yields potential drug target Scientists at UC Santa Barbara and several other institutions have found laboratory evidence that a cluster of peptides may be the toxic agent in Alzheimer's disease. Scientists say the discovery may lead to new drugs for the disease. Making nanoparticles in artificial cells Two new construction manuals are now available for the world's smallest lamps. Based on these protocols, scientists from the Max Planck Institute of Colloids and Interfaces have tailor-made nanoparticles that can be used as position lights on cell proteins and, possibly in the future as well, as light sources for display screens or for optical information technology. New Approach for Treating Recurrent Prostate Cancer on the Horizon A new study shows that an alpha-particle emitting radiopeptide-radioactive material bound to a synthetic peptide, a component of protein-is effective for treating prostate cancer in mice. Stress puts double whammy on reproductive system, fertility University of California, Berkeley, researchers have found what they think is a critical and, until now, missing piece of the puzzle about how stress causes sexual dysfunction and infertility. Are angiotensins involved in the hemodynamic changes of cirrhosis patients? Liver cirrhosis has been recently studied in the light of the new view of the renin angiotensin system (RAS). Scripps research team creates simple chemical system that mimics DNA A team of Scripps Research scientists has created a new analog to DNA that assembles and disassembles itself without the need for enzymes. Study shows animal mating choices more complex than once thought When female tiger salamanders choose a mate, it turns out that size does matter - tail size that is - and that's not the only factor they weigh. Nanoparticle created to attack cardiovascular plaque Scientists and engineers at UC Santa Barbara and the Burnham Institute for Medical Research have developed a nanoparticle that can attack plaque-a major cause of cardiovascular disease. Estrogen Linked to Lowered Immunity in Fish Exposure to estrogen reduces production of immune-related proteins in fish. This suggests that certain compounds, known as endocrine disruptors, may make fish more susceptible to disease. Novel biomarkers in heart failure Several new biomarkers have been recently described in Heart Failure (HF) syndrome either in stable chronic patients as in the settings of acute decompensation. More Peptides Current Events and Peptides News Articles |
|||||||||||||||||||||
|
|||||||||||||||||||||
|
|||||||||||||||||||||